chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started with a rash all over his body on 10/27/02. Seen by MD on 10/28/2002 with scattered papules all over his body but no scabs. He was given Benadryl and Caladryl scripts.
vomitting  ,fever, chills, severe joint pain in most joint, chills, days of fatigue,
This spontaneous case was reported by a pharmacist and describes the occurrence of IMMUNISATION REACTION (Reactogenicity), PRODUCT STORAGE ERROR (Lot was removed from the freezer on 28Feb2022 and placed in fridge at 2-8 degree Celsius and beyond use date was through 30 days(29Mar2022). 36 patients received vaccine from this lot between 31Mar2022 to 07Apr202) and EXPIRED PRODUCT ADMINISTERED (Lot was removed from the freezer on 28Feb2022 and placed in fridge at 2-8 degree Celsius and beyond use date was through 30 days (29Mar2022). 36 patients received vaccine from this lot between 31Mar2022 to 07Apr2022) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 016J21A-2A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Reactogenicity), PRODUCT STORAGE ERROR (Lot was removed from the freezer on 28Feb2022 and placed in fridge at 2-8 degree Celsius and beyond use date was through 30 days (29Mar2022). 36 patients received vaccine from this lot between 31Mar2022 to 07Apr2022) and EXPIRED PRODUCT ADMINISTERED (Lot was removed from the freezer on 28Feb2022 and placed in fridge at 2-8 degree Celsius and beyond use date was through 30 days (29Mar2022). 36 patients received vaccine from this lot between 31Mar2022 to 07Apr2022.). At the time of the report, IMMUNISATION REACTION (Reactogenicity), PRODUCT STORAGE ERROR (Lot was removed from the freezer on 28Feb2022 and placed in fridge at 2-8 degree Celsius and beyond use date was through 30 days(29Mar2022). 36 patients received vaccine from this lot between 31Mar2022 to 07Apr2022) and EXPIRED PRODUCT ADMINISTERED (Lot was removed from the freezer on 28Feb2022 and placed in fridge at 2-8 degree Celsius and beyond use date was through 30 days (29Mar2022). 36 patients received vaccine from this lot between 31Mar2022 to 07Apr2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. This case was linked to MOD-2022-553902 (Patient Link).
Approximately 12 hours after vaccination, I experienced chills, fever, sever muscle aches and joint pain, eventually sweating.  Symptoms subsided 24 hours after vaccination, and had  completely subsided by 48 hours after vaccination.
Swollen left elbow that decreased over time. Was still somewhat swollen 4 hours later. Pt reports she experiences no pain at the swollen site
Nausea, headache, muscle ache, lethargy. For about 16 hours starting 10 hours after the vaccination. Side effects lessened and after another 24 hours were completely gone.
Fever, measured at 99.5 at around 7:30 AM on 4/7/21 and 100.4 at around 2:00 PM, low grade headaches throughout morning.
Very sore right arm at the injection site; Had body aches head to toe; Difficulty lifting her right arm above her shoulder; Shaking / Trembling; This case was reported by a consumer via call center representative and described the occurrence of tremor in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th September 2019 14:00, the patient received the 2nd dose of Shingrix. In September 2019, 1 day after receiving Shingrix, the patient experienced general body pain and injected limb mobility decreased. On 26th September 2019 23:00, the patient experienced tremor. On 27th September 2019, the patient experienced injection site pain. The patient was treated with analgesic, nos (Analgesic). On an unknown date, the outcome of the tremor was recovered/resolved and the outcome of the injection site pain, general body pain and injected limb mobility decreased were unknown.   It was unknown if the reporter considered the tremor, injection site pain, general body pain and injected limb mobility decreased to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in right arm. The reporter stated that she received an email from GlaxoSmithKline asking her to report any side effects that she may experience with her 2nd dose of Shingrix. The reporter stated that the email was in regards to her call on day before reporting inquiring if she should take her flu shot along with her Shingrix, but decided to only get her Shingrix injection. The patient got her Shingrix vaccine on day before reporting at 2 pm, she was fine till she went to bed, at 11 pm where she started shaking and trembling for about an hour. The patient did some slow breathing and put extra blankets on her and after an hour it went away.  When the patient got up in morning of day of reporting, 1 day after vaccination she had body aches head to toe, she went for a walk in the yard for ten minutes, and the aches are starting to diminish. The patient also reported experiencing a very sore right arm at the injection site and has difficulty lifting her right arm above her shoulder. The patient had to have someone help her out of her sweatshirt because her arm was so sore. The patient declined in providing her doctor's contact information, provided caller information on duration of side effects and using analgesics for pain from Shingrix consumer frequently asked question. The reporter did not consent to follow up.
This spontaneous report was received from a registered nurse and refers to multiple unspecified patients of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medication were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of PROQUAD (Merck) (doses, routes of administration, injection sites, lot numbers and expiration dates were not reported). Administered doses of PROQUAD (Merck) underwent temperature excursion at 7 Fahrenheit degrees. At the time of reporting, the time frame of temperature excursion and information about the previous temperature excursions were unknown. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
at about hr 10 I began to feel very cold and progressed to severe shaking chills and rigors which lasted all night and into the next morning, I also had a low grade temp (which it is not outside of normal for vaccines) I also had severe body aches and severe headaches all of the first day post injection with body aches improving but still present today
The patient came into the office  on 12/20/21 and got administered Pfizer 5-11 and patient current age is 13 years old.
patient had nausea and enlarged lymph nodes with severe pain radiating down arm. referred to physician for follow up
Pt got home at 3pm. Pt passed out and fell down. Pt did not hit head, but did bite his tongue. Pt reported to feeling nauseated and tired the rest of the evening.
Second Shot: Bad headache, chills, body aches for 24 hrs.; Second Shot: Bad headache, chills, body aches for 24 hrs.; Body aches for 24 hrs.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 19Feb2021 (Lot number: EN6201) at the age of 38 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number : 1, Anatomical Location: Arm Left, Batch/lot number : EL3302, Time: 12:00), administration date: 23Jan2021, for COVID-19 Immunization, reaction(s): "Excessive thirst for 12 hrs". The following information was reported: CHILLS (non-serious), HEADACHE (non-serious) all with onset 19Feb2021, outcome "recovered" (20Feb2021) and all described as "Second Shot: Bad headache, chills, body aches for 24 hrs."; PAIN (non-serious) with onset 19Feb2021, outcome "recovered" (20Feb2021), described as "Body aches for 24 hrs.". Therapeutic measures were not taken as a result of chills, headache, pain.  Additional Information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The patient had no allergies to medications, food, or other products.  No follow-up attempts are possible. No further information is expected.
Within 5-10 minutes of receiving the vaccines the client began feeling "lightheaded" and became very pale. She and Mom had gone to the waiting room. Taken to a clinic room with and exam table to lie down on.  BP 98/60, P74. Given some apple juice and cold compresses were put on her neck and forehead.  After about 10 -15 minutes the pink color came back into her face.  BP, 98/62, P 72, BS 85.  She said that she had not eaten since earlier in the morning.  Mom said she thought that she had a seizure but that was not observed, a very short amount of syncope may have occured.  She has no history of a previous seizure.  Called and talked to Mom 8/6/19 she reports calling the clients MD but had to leave a message. No reports of any other events after leaving the office.
tired; headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired) and HEADACHE (headache) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 007M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 20-Mar-2021, the patient experienced FATIGUE (tired) and HEADACHE (headache). At the time of the report, FATIGUE (tired) and HEADACHE (headache) outcome was unknown.            No concomitant medications were reported.  It was unknown which arm  the patient received his Moderna covid-19 vaccine. Also, the immunization card stated 1ml of Moderna Covid-19 for each of his primary doses, however later it was reported as 0.5ml for his primary series.  No treatment medications were reported.   This case was linked to MOD-2022-525750, MOD-2022-525761 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Mar-2022: The recent follow-up received on 29-MAR-2022 contains no new information.
After the first dose within 10 minutes, I had itchy throat and mouth, heart palpitations, eyes felt like a fullness. After the second dose within 20 minutes, I had tightness in tongue and throat, upper eyelid swelling and redness and beet red flush like rash over cheeks. Next day swollen arm and small rash at injection site.
PATIENT RECEIVED 1 DOSE OF JANSSEN ON 08/020/2021 AT ONE LOCATION AND RECIEVED ANOTHER DOSE OF JANSSEN ON 08/23/2021.
Patient reported that her lips tingled and that she was having difficulty breathing at 11:00 am. An EMT onsite made contact with the patient and there were no signs of anaphylactic shock. EMS was contacted and responded. EMS evaluated the patient. Patient was not transported.
Pt vaccinated with DTP/OPV/HIB developed temp 104 the day after immunization.
she has had tingling up and down her left arm, hand and leg stating it feels like pins and needles; This is a spontaneous report from a contactable consumer or other non-Health Care Professional. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: Unknown), dose 1 via an unspecified route of administration on 08Mar2021 as 1ST DOSE, SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date the patient experienced she has had tingling up and down her left arm, hand and leg stating it feels like pins and needles. The outcome of event was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
recv vax 24OCT96 2PM & w/in 10min flet funny;BY 245PM unable to swallow, dysphoritic, diff breathing;BP 190/110;given med a/emergency transport to hosp;@ hosp recv more meds then adm to f/o  rxn triggering a MI d/c 25OCT96;
Pt called pharmacy Sat 9/9 and stated that the vaccine made her arm sore and was red and hot. I told her to put ice on the site and take BENADRYL. She came into the pharmacy on 9/10 to show me her arm. Her arm was very red and very swollen. She said it hurt to move any part of her arm and it was still hot. I suggested that she go see MD about it. Was worse and looked as if it was spreading past her elbow down. She came back with a prescription for clindamycin from the hospital ER.
I have had a low-grade fever for 4-6 weeks, always between 99.4 and 100. I am also experiencing aches and stomach issues. I had some type of a lung issue/bronchitis starting about May 1st or so, which has not resolved. In treating that, I tested negative for COVID, had a normal CBC and had a normal chest x-ray.
Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was not reported.
Within a day of 2nd Pfizer dose (intramuscular, left shoulder) had flu-like symptoms (aching joints, tired, chills, swelling under jawline, metallic taste in mouth) but they disappeared by third day from date of vaccination. By the 10th day after vaccination had developed intense shoulder pain radiating from shoulder to mid-arm (left arm) and upper back (trapezius/neck). Went to local Urgent Care next day and was X-rayed and given the following:  Methylprednisolone - 4MG (tapered dosage) ? Shoulder/trapezius muscle pain/inflammation Cyclobenzaprine - 10MG ? Muscle relaxant for shoulder/trapezius muscle pain/inflammation.  By end of tapered does still feeling intense ache/throb and pain in same areas.
Patient with shingles in the same dermatome that the vaccine was given.  This was culture confirmed to be varicella.
Patient notice 1 hive on leg, a few hours later had 4 large hives on both legs.  Went to see PMD, was prescribed prednisone dose pack.  One hive reduced in size few hours after medication.  Other hives still present.
Red blotches/hives on face, arms and then started itching within 2-3 minutes of getting intranasal vaccine. Family gave her BENADRYL which resolved allergic reaction.
Received the Moderna vaccine this morning and is pregnant; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Received the Moderna vaccine this morning and is pregnant) in a 28-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (Socially). Family history included Cancer. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Vitamin supplementation.    On 28-Dec-2020 at 7:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 11-Jul-2020 and the estimated date of delivery was 17-Apr-2021. On 28-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Received the Moderna vaccine this morning and is pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-fourth week of the pregnancy.  On 28-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (Received the Moderna vaccine this morning and is pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: This case concerns a 28-year-old, female G3P2 with medical history of prior social alcohol use who reported pregnancy. The first day of the patient's last menstrual period was on 11 Jul 2020. In August of 2020, the patient had a positive pregnancy test and the patient received mRNA-1273 on 28 December 2020. The estimated date of conception was unknown, and the due date was estimated as 17 April 2021.
Patient states received vaccines approximately 9 AM 1/31/08.  9 PM noted sore left jaw with difficulty opening mouth.  Still sore today.
significant arm swelling and erythema.  After each injection progressively worsened, after last injection - very severe erythema/swelling.
Throat and facial itching and rash after recieving immunizations and bicillin injections.
BONES HURT FOR WEEKS; HAVE NOT HAD A GOOD NIGHTS SLEEP; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the patient experienced bones hurt for weeks. On MAR-2021, the patient experienced have not had a good nights sleep. The action taken with covid-19 vaccine was not applicable. The patient recovered from bones hurt for weeks, and had not recovered from have not had a good nights sleep. This report was non-serious.
Information has been received from a lawyer and a consumer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medications were not provided. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX (lot# and route not provided) to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2016, a pharmacist administered the ZOSTAVAX vaccine to the patient. The patient was inoculated with the ZOSTAVAX vaccine to obtain permanent prevention and protection against shingles and zoster-related conditions. In January 2017, the patient was treated by a Nurse Practitioner for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX vaccine, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was not recovered. Causality assessment was related. Additional information has been requested.
Early morning June 12 after getting the shot on June 11: I had Nausea, headache, shivering, extreme tiredness, sore arm up to my neck. I had the shot Thursday June 11 and felt too sick to work on Friday June 12 or do any activity. It is now Saturday June 13 and I still have headache, a little nausea, sore arm, and tiredness.
chills; fever; muscle pain; nausea; stomach pain; tiredness/fatigue; This is a spontaneous report from a contactable consumer (patient) received via COVID-19 Vaccine Adverse Event Reporting System. A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: 59267-1000-02/EN6202), via an unspecified route of administration, administered in the left arm on 25Feb2021, at 15:15 (at the age of 61 years old) as dose 1, single for COVID-19 immunisation. Medical history included heart/ atrial tachycardia and known allergies: sufa (as reported). She was not pregnant at the time of report. Concomitant medications included sotalol (reported as sotalo6) 40 mg and 80 mg, pantoprazole, and aspirin. She did not receive any other vaccines prior to the COVID vaccine. The patient previously took magnesium and experienced allergies. On 26Feb2021, at 11:00, the patient experienced chills, fever, muscle pain, nausea, stomach pain, and tiredness/fatigue. The patient was not diagnosed with COVID-19 prior to vaccination and she has not been tested for COVID-19 since the vaccination. No therapeutic measures were taken as a result of the events. At the time of report, the patient has not recovered from the events.  No follow up attempts are possible. No further information is expected.
Father states: day after vaccine, very painful, 3 inch diameter redness, firm, hot, left deltoid. On 3/8/12 in PM pt went with father to E.R. Tx: cold compress & ALLEGRA.
Rash; Injection site burning and painful; Pain in the eyes; burning sensation in eye; This case was reported by a pharmacist via call center representative and described the occurrence of injection site rash in a 71-year-old female patient who received Herpes zoster (Shingrix) (batch number 7457P, expiry date unknown) for prophylaxis.   On 29th July 2019, the patient received Shingrix. On 31st July 2019, 2 days after receiving Shingrix, the patient experienced injection site rash, injection site burning, eye pain and burning sensation in eye. On an unknown date, the outcome of the injection site rash, injection site burning, eye pain and burning sensation in eye were unknown.   It was unknown if the reporter considered the injection site rash, injection site burning, eye pain and burning sensation in eye to be related to Shingrix.  Additional details were provided as follows: The injection site was burning and painful and it looked like a rash. The patient also had presented with these symptoms in her eye. These symptoms might have started yesterday of reporting date. The reporter did not consent to follow-up.
Employee reports - hives 48 hours after immunization then @ 72 hours arthralgia and swelling @ all joints and increased hives into throat area - X 2 trips to ED and was given prednisone PO and resolved by 12/25/09.